Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Richard Ross

Concepts (50)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Head and Neck Neoplasms
3
2024
561
0.430
Why?
Receptor, EphB4
1
2024
33
0.210
Why?
Ephrin-B2
1
2024
45
0.210
Why?
Calcitonin Gene-Related Peptide
1
2024
40
0.200
Why?
Cancer Pain
1
2024
39
0.200
Why?
Spiral Cone-Beam Computed Tomography
1
2023
5
0.200
Why?
Bone Neoplasms
1
2024
255
0.180
Why?
Pancreatectomy
1
2024
287
0.170
Why?
Neoadjuvant Therapy
1
2024
465
0.160
Why?
Deoxycytidine
1
2022
220
0.160
Why?
Feasibility Studies
1
2024
1109
0.150
Why?
Graft vs Host Disease
1
2022
278
0.150
Why?
Combined Modality Therapy
1
2022
1264
0.140
Why?
Adenocarcinoma
1
2024
920
0.120
Why?
Hematopoietic Stem Cell Transplantation
1
2022
698
0.120
Why?
Palliative Care
1
2024
1017
0.120
Why?
Pancreatic Neoplasms
1
2024
926
0.110
Why?
Tumor Microenvironment
2
2024
733
0.080
Why?
Radiotherapy, Adjuvant
1
2024
221
0.050
Why?
Cone-Beam Computed Tomography
1
2023
32
0.050
Why?
Chemotherapy, Adjuvant
1
2024
423
0.050
Why?
Epithelial-Mesenchymal Transition
1
2024
219
0.050
Why?
Mice
3
2024
18303
0.050
Why?
Pain Measurement
1
2024
554
0.040
Why?
Neoplasm Metastasis
1
2024
688
0.040
Why?
Humans
6
2024
145140
0.040
Why?
Quality of Life
2
2024
3194
0.040
Why?
Pain Management
1
2024
409
0.040
Why?
Bone Marrow
1
2022
306
0.040
Why?
Transplant Recipients
1
2022
180
0.040
Why?
Survival Rate
1
2024
2087
0.040
Why?
Software
1
2023
678
0.030
Why?
CD8-Positive T-Lymphocytes
1
2024
917
0.030
Why?
CD4-Positive T-Lymphocytes
1
2024
1138
0.030
Why?
Animals
3
2024
37952
0.030
Why?
Cell Line, Tumor
1
2024
3539
0.030
Why?
Prognosis
1
2024
4310
0.030
Why?
Reproducibility of Results
1
2023
3410
0.030
Why?
Follow-Up Studies
1
2024
5411
0.030
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2024
1958
0.030
Why?
Disease Progression
1
2022
2857
0.030
Why?
Aged
2
2024
26096
0.030
Why?
Middle Aged
2
2024
36126
0.020
Why?
Male
3
2024
72664
0.020
Why?
Prospective Studies
1
2024
8035
0.020
Why?
Aged, 80 and over
1
2024
8318
0.020
Why?
Signal Transduction
1
2024
5208
0.020
Why?
Adult
2
2024
40665
0.020
Why?
Female
2
2024
78636
0.010
Why?
Retrospective Studies
1
2024
17247
0.010
Why?
Ross's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)